Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV Gliomas
Clinical trial NCT02454634 · COMPLETED
Trial details
- NCT number
- NCT02454634
- Sponsor
- National Center for Tumor Diseases, Heidelberg
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-09-19
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.